Translation, Cross-Cultural Adaptation, and Validation of the Pain Sensitivity Questionnaire in Dutch Healthy Volunteers by Van Boekel, Regina L M et al.
 
 
 University of Groningen
Translation, Cross-Cultural Adaptation, and Validation of the Pain Sensitivity Questionnaire in
Dutch Healthy Volunteers
Van Boekel, Regina L M; Timmerman, Hans; Bronkhorst, Ewald M; Ruscheweyh, Ruth;
Vissers, Kris C P; Steegers, Monique A H
Published in:
Pain research & management
DOI:
10.1155/2020/1050935
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Van Boekel, R. L. M., Timmerman, H., Bronkhorst, E. M., Ruscheweyh, R., Vissers, K. C. P., & Steegers,
M. A. H. (2020). Translation, Cross-Cultural Adaptation, and Validation of the Pain Sensitivity Questionnaire
in Dutch Healthy Volunteers. Pain research & management, 2020, [1050935].
https://doi.org/10.1155/2020/1050935
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 26-12-2020
Research Article
Translation, Cross-Cultural Adaptation, and Validation of the
Pain Sensitivity Questionnaire in Dutch Healthy Volunteers
Regina L. M. Van Boekel ,1 Hans Timmerman,1,2 Ewald M. Bronkhorst,3
Ruth Ruscheweyh,4 Kris C. P. Vissers ,1 and Monique A. H. Steegers1,5
1Department of Anesthesiology Pain and Palliative Medicine, Radboud University Medical Center, Nijmegen, Netherlands
2Department of Anesthesiology, Pain Center, University Medical Center Groningen, Groningen, Netherlands
3Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands
4Department of Neurology, Ludwig Maximilians University of Munich, Munich, Germany
5Department of Anesthesiology, Amsterdam University Medical Center, Location VU, Amsterdam, Netherlands
Correspondence should be addressed to Regina L. M. Van Boekel; rianne.vanboekel@radboudumc.nl
Received 24 January 2020; Accepted 3 June 2020; Published 25 July 2020
Academic Editor: Michal Granot
Copyright © 2020 Regina L. M. Van Boekel et al. (is is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in anymedium, provided the original work is
properly cited.
An increased sensitivity to painful stimuli has been proposed to be related to the development of chronic pain. (erefore,
assessment of individual pain sensitivity is useful in clinical practice. However, experimental pain testing may be uncomfortable
for patients and requires specific equipment.(e Pain Sensitivity Questionnaire (PSQ) has been developed to facilitate assessment
of pain sensitivity. In this study, we aimed to translate and cross-culturally adapt the PSQ from its published German and English
versions into the Dutch language and to assess validity of the PSQ in healthy volunteers. After translation and cross-cultural
adaptation of the PSQ following international guidelines, we validated the PSQ in 394 healthy volunteers by comparing the PSQ-
values with two different experimental pain tests: electrical pain tolerance (EPT) and pressure pain threshold (PPT). In addition,
ratings of pain intensity during these tests were obtained on the numerical rating scale (NRS, 0–10).We found that the reliability of
the PSQ based on internal consistency was good (Cronbach’s alpha 0.90). PSQ-scores, adjusted for age and sex, were statistically
significant and weakly inversely correlated to EPT (PSQ-moderate: rho� −0.24, p � 0.007; PSQ-total: rho� −0.22, p � 0.016). No
statistically significant correlation between PSQ-scores and PPTwas found. Concerning the pain scores, PSQ-scores were weakly
to moderately correlated to EPT-NRS (PSQ-minor: rho� 0.21, p � 0.021; PSQ-moderate: rho� 0.22, p � 0.016; PSQ-total:
rho� 0.23, p � 0.009) as well as PPT-NRS (PSQ-minor: rho� 0.32, p< 0.001; PSQ-moderate: rho� 0.36, p< 0.001; PSQ-total:
rho� 0.37, p< 0.001). (erefore, we concluded that the Dutch version of the PSQ is culturally appropriate for assessing self-
reported pain sensitivity in healthy volunteers.
1. Introduction
Increased pain perception and pain sensitivity may be re-
lated to the development of chronic pain [1]. (e need for a
proper assessment of individual pain sensitivity is well
known, since pain sensitivity may influence initial pain
experiences and treatment outcome [2, 3]. Experimental
determination of a patients’ pain sensitivity is possible by
quantitative sensory testing (QST) using different stimula-
tion modalities such as thermal, mechanical, ischemic, or
electrical stimulation [4, 5]. Ruscheweyh and coworkers
developed the Pain Sensitivity Questionnaire (PSQ) to easily
measure patients’ pain sensitivity in daily clinical practice
without experimental determination of patient’s pain [6].
(e PSQ is based on pain intensity rating of imagined
painful daily life situations. (e validity of the PSQ to
measure perceived pain sensitivity has been shown by sig-
nificant correlations with experimental pain intensity, both
in healthy subjects and in patients with chronic pain [6, 7].
In contrast, correlations with experimental pain thresholds
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were lower or absent [6]. Besides the original version in the
German language [6], the PSQ is translated into and vali-
dated in English [8], French [9], Polish [10], Korean [11],
Persian [12], Mandarin [13], and Norwegian [14]. Moreover,
the PSQ has been used to identify pain sensitivity in several
studies: to predict surgical success in patients with lumbar
disc herniation [12, 15] and lumbar stenosis [16], to predict
postoperative pain and development of chronic pain in
patients after spine surgery [17], and to predict acute
postoperative pain following surgery for breast cancer [18].
It is also used to understand ocular discomfort and dryness
[19], in epidemiological health research [20], to explore
associations with widespread pain in patients with shoulder
pain [21], and to discriminate in the pain behavior of pa-
tients with chronic pain with or without central sensitization
[22].(e correlation between ethnic differences and clinical
pain response was also studied by use of the PSQ [23].
According to these previous results, the PSQ might be a
clinical useful instrument to screen patients’ pain sensitivity
in the Netherlands. However, in order to use this tool in a
Dutch population, the PSQ needs to undergo a translation
into the Dutch language. (e next step is to validate the new
Dutch version of the PSQ in a population of healthy vol-
unteers. (erefore, the aim of this study was to translate and
cross-culturally adapt the PSQ from the published English
and German versions into the Dutch language and to val-
idate this instrument in a large group of healthy volunteers
by comparing PSQ-scores with the results of experimental
pain testing.
2. Methods
2.1. Translation and Cross-Cultural Adaptation of the PSQ to
the Dutch Language. Permission was obtained from the
initial developers (Ruscheweyh and coworkers) to develop
and cross-culturally adapt a Dutch version of the PSQ and to
validate this Dutch version of the PSQ against experimental
pain testing. (e validated German and English versions of
the PSQ from the study of Ruscheweyh and coworkers [6, 8]
were translated into the Dutch language according to in-
ternational guidelines [24] (see Figure 1). A native German
speaking bilingual physician and researcher translated the
original German version into Dutch. On the basis of the
English version, two independent official bilingual, native
Dutch speaking translators, of which one had a medical
background, independently translated the PSQ from English
into Dutch. (e two Dutch versions were put together and
after careful consideration combined into one new Dutch
version. Afterwards, this Dutch version was back translated
into English by two independent official bilingual English
translators, of which one had a medical background, and
compared to the original English version. (is new English
version was compared to the original English version, and
some items were discussed (see Table 1). To assess face
validity and a qualitative evaluation, a pilot test was con-
ducted with twenty patients waiting to undergo different
kinds of surgery, such as orthopedic, abdominal, or gyne-
cological surgery. Patients did not report any difficulties
when filling in the questionnaire, nor did they report any
elements of discussion. Because the cognitive debriefing left
the PSQ-Dutch unchanged, the questions in the question-
naire were considered to be adequate and understandable.
(e native German speaking bilingual researcher compared
the original German PSQ with his own translation and the
final PSQ-Dutch. (e PSQ-Dutch was also found to be
similar to the original German questionnaire. In conclusion,
the pilot test phase of the PSQ-Dutch showed no necessities
for adjustments (see Supplement S1 for the Dutch version of
the Pain Sensitivity Questionnaire (PSQ-Dutch)).
2.2. Validation of the PSQ
2.2.1. Design. (is observational study took place in 2016
during “Lowlands,” a 3-day festival with special attention for
science, in Biddinghuizen, Netherlands. (e study was
conducted according to the Helsinki Declaration and was
approved by the local research ethics committee on human
research (Medical Review Ethics Committee Region Arn-
hem-Nijmegen) beforehand. It is registered as file number
CMO: 2016–2784.
2.2.2. Participants. Participants were recruited by members
of the research team when passing by the study facility. All
participants were 18 years or older and could speak and read
the Dutch language. All participants gave a written informed
consent. Participants received no financial compensation for
their cooperation. Exclusion criteria were as follows: use of
pain killers in the last 12 hours, use of antidepressants, pain
of the arm, neck or shoulder (uni- or bilaterally), cardiac
disease, psychiatric or neurological disease, injury to the
forearms or hands, Raynaud disease, pregnancy, blood al-
cohol content (BAC) of >220 μg/l, or use of recreational
drugs in the past 24 hours. Participants were tested for their
blood alcohol content by a physician, via breath analysis.
2.2.3. Test Methods
(1) Pain Sensitivity Questionnaire. Participants filled in the
questions of the PSQ directly after being included in the
study. (e PSQ consists of 17 questions, which describe
situations in daily life. Respondents score their pain intensity
of the described situation ranging from 0 (not painful) to 10
(strongest pain imaginable) on a numeric rating scale.
Fourteen questions represent situations that the majority of
healthy subjects consider painful. (ree questions represent
nonpainful situations as perceived by most people. (ese
three questions are used as a nonpainful sensory reference
for the participants and are not included in the final scoring.
A diversity of pain modalities such as hot, cold, sharp, and
blunt, as well as different parts of the body such as head,
upper extremity, and lower extremity, are included in the
questionnaire. (e PSQ-total score is formed as the average
of the fourteen “painful” items of the PSQ, all ranging from 0
to 10. Two subscores have been derived from factor analysis,
the PSQ-minor (including items that on average are asso-
ciated with minor pain) and the PSQ-moderate score
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Step 6: harmonization
Original German version, PSQ German to Dutch version, F1, F2, F1-2, B1, B2, B1-2
all translations were discussed, linguistically and culturally, by the research team, and the most fitted
adaptation to the Dutch language and culture was combined into a definitive Dutchv ersion: PSQ-Dutch.
Three items were changed at this point (Table 1).
Step 7: cognitive debriefing
The prefinal version was tested among 20 Dutch adult patients, waiting to undergo surgery. Participants
were asked to comment on clarity, readability, and comprehensibility of the PSQ-Dutch. All patients could
easily fill in the PSQ-Dutch and reported no difficulties.
Step 8: review of the cognitive debriefing results and finalization
The team approved the final version to be used in the study, since the patients did not report any difficulties
when filling in the questionnaire, nor did they report any elements of discussion.
Step 9: proofreading
The final version was proofread for spelling or grammatical errors, of which none were found.
Afterwards, the final version (PSQ-Dutch) was validated in a Dutch cohort.
Step 10: final report
The process of translation and cross-cultural adaptation of the PSQ-Dutch was documented.
Step 1: preparation
Permission was obtained from the author of the PSQ to develop a Dutch version of the PSQ.
Step 2: forward translation
by native Dutch speaker, fluent in
English: F1.
Step 2: forward translation







researcher of the team
into
Dutch version.
Step 3: reconciliation (translation F1-2)
Both translations were discussed, linguistically and culturally, by the two
translators and combined into a new Dutch version F1-2.
Step 4: back translation
by native English speaker, fluent in
Dutch: B1 translation.
Step 4: back translation
by native English speaker, fluent
in Dutch: B2 translation.
Step 5: back translation review (translation B1-2)
Both translations were discussed, linguistically and culturally, by the two
translators and combined into a new English version B1-2.
Figure 1: Flow diagram of the translation and cross-cultural adaptation process.
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(including items that on average are associated with mod-
erate pain) [6]. (e PSQ-minor consists of the mean rating
of questions 3, 6, 7, 10, 11, 12, and 14. (e PSQ-moderate
consists of the mean rating of questions 1, 2, 4, 8, 15, 16, and
17. In the original study of Ruscheweyh and coworkers, the
internal consistency measured by Cronbach’s alpha was 0.92
for the PSQ-total, 0.81 for the PSQ-minor, and 0.91 for the
PSQ-moderate [6].
(2) Quantitative Sensory Testing. After completing the self-
administered PSQ, participants waited until a researcher was
able to perform QST. (e pain thresholds were assessed in
the healthy volunteers in reaction to painful electrical and
pressure stimuli based on the Nijmegen–Aalborg screening
quantitative sensory testing as described in earlier published
research [25–27]. (e twelve operators were trained thor-
oughly in the application of both stimuli in a training session
for this study. In the training session, application of both
stimuli was optimized and calibrated, as well as a uniform
approach of participants. Instructions were standardized
and read to each volunteer from an instruction sheet. To
minimize distraction, participants were seated at tables in
one of six separated cubicles facing the operator who was
carrying out the measurements to create a low diverting
environment and create the same ambient conditions.
Moreover, protective industrial earmuffs (3M Peltor Optime
III H540, Maplewood, MN, USA) were placed over the ears
in order to minimize the influence of background noise.
(ere were two cubicles for electrical stimuli and four cu-
bicles for pressure stimuli. Measurements were performed
on predetermined sites on the dorsal side of the nondom-
inant forearm [28, 29]. (e rationale for this location was
based on the choice of performing the measurements on an
easy assessable location with enough muscle size to measure
the PPT. Moreover, this is also a location which is ap-
proachable by only uncovering the forearm but without
undressing of the volunteer before performing the mea-
surements. Participants were randomized to either the
electrical or the pressure stimulus by picking a blinded
envelope containing the protocol. First, a test measurement
was performed to acquaint the participant with the
procedure (M0). (is was followed by the experimental
stimulus used for analysis (M1).
(3) Electrical Pain Tolerance (EPT). (e EPT is the level of
pain caused by an electrical current (expressed in milli-
ampere, mA) which is as high as the participant could
tolerate. To measure the EPT, the QST-3 device (JNI Bio-
medical ApS, Klarup, Denmark) was used. For the electrical
pain stimuli, the electrodes (Kendall ECG Electrodes,
H34SG, 50× 45mm; Covidien, Mansfield, MA, USA) were
fixed at 10 and 6 centimetres from the styloid process of the
ulna on the dorsal side of the nondominant forearm. (e
stimulator was set to deliver tetanic stimulation (100Hz,
0.2ms square waves) with a ramping rate of 1mA/s. (e
initial current was set to 0mA. For safety reasons, the
maximum electrical current was limited to 50mA. (e
participant was instructed to press a button to start the
current and to release the button when the pain became
intolerable.
(4) Electrical Pain Tolerance Numerical Rating Scale (EPT-
NRS). Participants were asked to rate the pain intensity
experienced during the electrical pain tolerance, using the
numerical rating scale (NRS) directly after the test. (e level
of pain was expressed on a NRS from zero (no pain) to ten
(worst imaginable pain). (e psychometric properties of the
NRS are well supported, and the NRS is considered to be
responsive and able to detect sex differences in pain intensity
[30].
(5) Pressure Pain 3reshold (PPT). To measure the PPT, a
digital pressure algometer with a 1.0 cm2 probe (Wagner
Instruments, Force TENTM Digital Force Gage FDX 50,
Greenwich, CT, USA) was used. (e measurement locations
were at 12 and 10 centimetres from the styloid process of the
ulna and corresponded with the two measurements (M0,
M1). (e pressure was delivered under a 90° angle on the
muscles on the dorsal side of the nondominant forearm. We
used a ramping rate of ∼5N/s by manually adjusting the
applied pressure via visual feedback on the algometer dis-
play. PPT was expressed in Newton (N). Pressure started at
Table 1: Comparison of items in the original German PSQ with the published English PSQ for cross-cultural translation into the Dutch
language.
Item number Original German PSQ Published English PSQ Final Dutch PSQ Reasons for change
[Instructions]
Sie sollen dann entscheiden,
ob diese situation für sie
schmerzhaft wäre, und wenn
ja, wie schmerzhaft sie wäre
You should then decide if
these situations would be
painful for you, and if yes,
how painful they would be
Het is de bedoeling dat u van
elke situatie bepaalt of deze
pijnlijk voor u zou zijn en zo
ja, hoe pijnlijk
“Sie sollen”/“You should” can
be translated into the Dutch
“moeten,” which is very
demanding. Choice conforms
to German PSQ formal
language
[1–17] Stellen sie sich vor, sie. . . Imagine. . . Stelt u zich voor dat Conforming to the GermanPSQ usage of formal language
[10]
Stellen sie sich vor, sie haben
eine kleine Verletzung am
Finger und bringen aus
Versehen Zitronensaft in die
Wunde
Imagine you have a minor
cut on your finger and
inadvertently get lemon
juice in the wound
Stelt u zich voor dat u een
sneetje in uw vinger heeft en
dat er per ongeluk citroensap
in het wondje komt. Hoe
pijnlijk zou dat voor u zijn?
Usage of diminutive for
wound, which may feel as a
very big wound in Dutch
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0N and was applied up to a maximum of 250N for safety
purposes. (e participants were instructed to say “stop”
when they felt, besides the feeling of pressure, a burning,
painful, or stitching sensation.
(6) Pressure Pain 3reshold Pain Intensity Rating. Partici-
pants were asked to rate the pain intensity experienced
during the pressure pain threshold, using the NRS directly
after the test.
(7) Statistical Methods. Age and the PSQ-scores as well as the
experimental pain scores were summarized as mean
(standard deviation (SD)) and/or median (interquartile
range (IQR)). Relative frequencies were calculated for
nominal variables, such as sex.
(e PSQ-total, PSQ-minor, and PSQ-moderate scores
were evaluated for reliability by internal consistency using
Cronbach’s alpha. Since twelve researchers performed
electrical and pressure pain tests, we tested for operator
effects, using one-way ANOVA, with Tukey’s post hoc
testing with Bonferroni correction for multiple comparisons.
Construct (convergent) validity was tested by evaluating the
correlations between the PSQ and the experimental pain
measures using Spearman’s rank correlation coefficient [31].
Partial correlation coefficients between PSQ-scores and
experimental pain scores, adjusted for age and sex as po-
tential confounders [14], were calculated.
Data were analyzed using SPSS (IBM Corp. Released
2013. IBM SPSS Statistics for Windows, Version 22.0,
Armonk, NY: IBM Corp.) and R (R version 3.4.0; R
Foundation for Statistical Computing, Vienna, Austria). For
all tests, p value <0.05 was considered statistically significant.
3. Results
3.1. Participants andBaselineCharacteristics. (e enrolment
process is shown in Figure 2. A total of 484 volunteers were
assessed for participation. 67 volunteers were excluded,
because they failed to meet the inclusion criteria (n � 1);
declined to participate (n � 8); had drunk alcohol (n � 39);
had taken recreational drugs (n � 10); had a painful arm
(n � 1); had an open wound on their arm (n � 1); suffered
from neurological (n � 1), psychiatric (n � 1), or cardiac
diseases (n � 1); or had taken antidepressant (n � 2) or
analgesic drugs (n � 2). Data from an additional 23 par-
ticipants were excluded after performing the experiment.
During data entry, the data of two participants were ex-
cluded from the study as it was unclear if they had the
electrical or pressure pain test. During analysis, the data of
21 participants were excluded because of missing data on
sex or the PSQ.(e data of the remaining 394 subjects were
used for the final analysis. 132 and 262 participants took
part in the electrical and the pressure pain test, respectively,
which was due to the availability of the measurement
equipment.
A small majority of the total cohort were female (54.8%),
and the median age of the participants was 26 years (IQR
22–32; range 18–60 years). (e distribution of age and sex of
the study participants is shown in Table 2.
3.2. PSQ-Scores. Scores of the Dutch PSQ are reported in
Table 2. For PSQ-total, -moderate, and -minor, the mean
was, respectively, 4.1, 5.3, and 2.8. Reliability was measured
by internal consistency. Cronbach’s alpha was 0.90 for PSQ-
total, 0.86 for PSQ-moderate, and 0.82 for PSQ-minor.
3.3. Experimental Pain Testing. Table 2 shows the results of
both electrical and pressure pain testing. Regarding the
analysis of operator effects, there were no statistically sig-
nificant differences between group means of EPT as deter-
mined by one-way ANOVA (p � 0.496). Regarding PPT, the
analysis revealed a statistically significant difference
(p< 0.001) in the group mean of one operator compared to
some other operators caused by some extreme values in PPT
data. (erefore, we performed a sensitivity analysis by re-
peating all analyses without the data of this operator. No
meaningful differences in the results were shown, so the
results of the original data analyses are presented.
3.4. Construct Validity. Construct validity was evaluated by
examining the correlations between the PSQ-Dutch and the
experimental pain measures using Spearman’s rank corre-
lation coefficient. As shown in Table 3, no correlation was
found between pressure pain threshold and any of the PSQ-
scores. However, there was a statistically significant, but
weak correlation between electrical pain tolerance and PSQ-
moderate (rho� −0.19), and statistically significant weak to
moderate correlations (rho� 0.22 to 0.40) between the PSQ-
scores and the pain intensity ratings of both electrical and
pressure pain tests (see Table 3 and Figures 3 and 4).
3.5. Confounding Variables. (e experience of pain may be
influenced by confounding factors; therefore, partial corre-
lation coefficients between PSQ-scores and experimental pain
scores, adjusted for age and sex, were calculated (see Table 3).
As shown in Table 3, PSQ-moderate and PSQ-total, adjusted
for age and sex, were weakly inversely correlated to EPT and
showed statistical significance (PSQ-moderate: rho� −0.24;
PSQ-total: rho� −0.22). No statistically significant correlation
between PSQ-scores and PPTwas found. Concerning the pain
scores, all PSQ-scores were statistically significant and weakly
to moderately correlated to EPT-NRS (PSQ-minor:
rho� 0.21; PSQ-moderate: rho� 0.22; PSQ-total: rho� 0.23)
as well as PPT-NRS (PSQ-minor: rho� 0.32; PSQ-moderate:
rho� 0.36; PSQ-total: rho� 0.37).
4. Discussion
In this study, the PSQ was translated and cross-culturally
adapted from both the English and German versions into the
Dutch language. Furthermore, the instrument was validated
in healthy volunteers. We found that the reliability via in-
ternal consistency of the PSQ-Dutch was high and that
statistically significant correlations of weak to moderate
magnitude were present between (1) the PSQ-moderate and
PSQ-total and electrical pain tolerance and (2) all PSQ-
scores and pain intensity ratings of both electrical and
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pressure pain stimuli. In contrast, there was no statistically
significant correlation between PSQ and pressure pain
thresholds. (ese relationships were maintained after con-
trolling for age and sex.
We used the electrical pain tolerance as well as the
pressure pain threshold [25, 26, 32]. Pain should be seen as a
multidimensional, individual, and personal perception.
Following our colleagues [33], it is therefore important that
Participating healthy volunteers (N = 417)
Excluded (N = 2)









Data for analysis (N = 394)
Assessed for eligibility (N = 484)
Excluded (N = 67)
Not meeting inclusion criteria (N = 1)
Declined to participate (N = 8)




Figure 2: Flow diagram of the validation study. EPT: electrical pain tolerance measurement; PPT: pressure pain threshold measurement.
Table 2: Characteristics of the participants.
Total Male Female
n n n
394 178 (45.2%) 216 (54.8%)
Age (year)
18–28 90 50.6 137 63.4
29–38 48 27.0 55 25.5
39–48 22 12.4 10 4.6
49–58 8 4.5 5 2.3
59–68 1 0.6 1 0.5
Missing 9 5.1 8 3.7
PSQ-minor (mean± SD) 2.8 (±1.3)
PSQ-moderate (mean± SD) 5.3 (±1.5)
PSQ-total (mean± SD) 4.1 (±1.3)
EPT (mA, median, IQR) 132 21.1 (15.0 – 27.1)
NRS-EPT (median, IQR) 7.0 (6.0 – 8.0)
PPT (N, median, IQR) 262 59.4 (41.6 – 92.2)
NRS-PPT (median, IQR) 3.0 (2.0 – 5.0)
SD: standard deviation; mA: milliampere; n: number of participants; EPT: electrical pain tolerance; PPT: pressure pain threshold; SD: standard deviation;
NRS: numerical rating scale; IQR: interquartile range; N: Newton.
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Table 3: Correlation between PSQ measures and QST measures (n� 394: EPT n� 132; PTT n� 266).
EPT EPT-NRS PPT PPT-NRS
Rho p Rho p Rho p Rho p
PSQ-minor Crude −0.120 0.171 0.217 0.012 −0.074 0.235 0.349 <0.001
Adjusted for age and sex −0.170 0.059 0.207 0.021 −0.106 0.097 0.324 <0.001
PSQ-moderate Crude −0.187 0.032 0.232 0.007 −0.032 0.611 0.378 <0.001
Adjusted for age and sex −0.239 0.007 0.216 0.016 −0.044 0.490 0.363 <0.001
PSQ-total Crude −0.165 0.059 0.243 0.005 −0.052 0.397 0.395 <0.001
Adjusted for age and sex −0.216 0.016 0.233 0.009 −0.078 0.222 0.374 <0.001














Rho = −0.17, p = 0.059
(a)
R2 linear = 0,126
2 4 6 8
PSQ-total












Figure 3: Illustration of the correlations between total score of the Pain Sensitivity Questionnaire (PSQ) and results of experimental
electrical pain testing. (a) Correlation between the total score of PSQ (PSQ-total) and the electrical pain tolerance (EPT). (b) Correlation
between the total score of PSQ (PSQ-total) and the electrical pain tolerance numerical rating scale (EPT-NRS). Linear regression lines are











R2 linear = 0,001











R2 linear = 0,164
10
8
Rho = 0.395, p < 0.001
0 2 4 6 8
(b)
Figure 4: Illustration of the correlations between total score of the Pain Sensitivity Questionnaire (PSQ) and results of experimental
pressure pain testing. (a) Correlation between the total score of PSQ (PSQ-total) and the pressure pain threshold (PTT). (b) Correlation
between the total score of PSQ (PSQ-total) and the pressure pain threshold numerical rating scale (PTT-NRS). Linear regression lines are
displayed, and Spearman’s correlation coefficients (rho) as well as p values are given (n� 262).
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the response to a single, standardized stimulus is seen as a
very limited part of the pain experience of a person. Because
of this fact, we chose to use different stimuli (electrical and
mechanical stimuli) and assessment techniques (threshold
and suprathreshold response) to obtain more comprehen-
sive information on nociceptive processing. As stated by
Neziri et al. [34], both tests could be used for the assessment
of pain hypersensitivity in patients.
(e weak tomoderate correlations we found in our study
are comparable to those found in the original validation
study as well as in the other language versions. Moreover, the
reliability of the PPT and EPT was, based on other studies,
acceptably high [35, 36]. However, the choice for electrical
pain measurements in our study differs from the heat, cold,
and pinprick measurements as used in the original study of
Ruscheweyh [6] and in their validation study in patients with
chronic pain [7], but the pressure pain algometry as an
outcome measure was comparable between the studies of
Ruscheweyh and our study. In the Mandarin Chinese ver-
sion, similar to our study, electrical pain threshold and
electrical pain tolerance were used [13]. In the Norwegian
version, a comparison was made with the outcome of a heat
pain threshold test and a cold pressor test [14]. In the English
validation study, injection with lidocaine was used as a
noxious stimulus [8]. (e Polish [10], Korean [11], and the
Iranian [12] studies regarding the validity of the PSQ did not
use experimental pain sensitivity as a comparison, but other
questionnaires, such as the Pain Catastrophizing Scale [37].
We believe that validation of a questionnaire reflecting an
objective pain measure may be more reliable if tested with
objective experimental pain measurement.
In our study, the score means of the PSQ were 4.1± 1.3
(PSQ-total), 2.8± 1.3 (PSQ-minor), and 5.3± 1.5 (PSQ-
moderate) (see Table 2). (e score means in the German
version of the PSQ were somewhat lower: 3.6± 1.2 (PSQ-
total), 2.5± 1.1 (PSQ-minor), and 4.7± 1.6 (PSQ-moderate)
[6]. (e score means of the Chinese version of the PSQ were
a bit higher compared to the score means of the German and
Dutch version of the PSQ: 4.7± 1.6 (PSQ-total), 3.9± 1.6
(PSQ-minor), and 5.5± 1.9 (PSQ-moderate) [13]. (e dif-
ferences between the PSQ-scores in the countries as stated
above might be due to cultural differences or differences in
the populations of healthy volunteers. Moreover, larger
group inhomogeneity and differences in people who were
carrying out the measurements might have played a role.
Construct validity was demonstrated by the presence of
correlations between the results of experimental pain tests
and the PSQ. It has been previously reported that the PSQ
shows little or no correlation with experimental pain
thresholds but substantial correlations with experimental
pain intensity ratings, and this has been interpreted within a
framework of pain thresholds and pain intensity ratings
representing two different dimensions of pain sensitivity
[6, 7]. Consistently, the present results show no statistical
significant correlation between PSQ and PPTs, but statistical
significant correlations between the PSQ and pain intensity
ratings of both experimental pain stimuli used.
(e relation between experimental pain tolerance and
the PSQ has been less explored. One previous study reported
correlations around r� −0.2 between PSQ-scores and elec-
trical pain tolerance, which is very similar to our results [13].
(ere are however some differences between the measure-
ments by Quan et al. [13] and our methodology. We used an
alternating current (AC), whereas Quan et al. used a direct
current (DC), and this difference is responsible for the much
higher level of current in our study because the sensation of
AC and DC is different. Moreover, our participants were
able to abort the current by themselves instead of by the
operator, which might give the participant more feeling of
control. In addition, we included a bigger and probablymore
homogeneous population of participants.(is all might have
led to the differences in the current intensity between both
studies but also makes both studies less comparable.
(e perceived pain intensity during the measurement of
the electrical pain tolerance was in the study of Quan et al. (via
VAS) 6.21± 2.02.We found for the same assessment modality
a pain intensity of 7 (IQR 6–8), which seems comparable.(e
present results show that the PSQ-Dutch represents mainly
the pain intensity rating dimension of pain sensitivity, as
previously shown for the original German version [6].
(e strengths of this study are firstly the cross-cultural
adaptation performed via an internationally established
guideline. Secondly, the pain sensitivity measurements were
adequately standardized and trained in beforehand. More-
over, the study population consisted of a large sample of
both men and women.
In this study, we noticed some weaknesses. In our study
population, we noticed that most study participants had an
age between 18 and 38 years, thus leading to a rather ho-
mogeneous study sample of healthy volunteers. We also
found that the median PPT of one of our operators was
statistically significantly different, due to some extreme
values of PPTdata. (ese extreme values however were valid
and reliable data, and the removal of the data of this operator
made no substantive difference in the results. (erefore, we
chose not to remove them from our dataset to avoid the risk
of selection bias and type 1 error [38, 39]. Because of the
study set-up during a three-day event, test-retest reliability
could not be assessed. An interval of preferably one to four
weeks, which is considered to be reflective for daily life and/
or of clinical relevance, could not be reached. To minimize
the burden due to pain stimuli and length of the total
procedure for the participants, only one kind of pain stimuli
(PPT or EPT) was given. In the validation studies of the
English [8] as well as the Chinese version of the PSQ [13],
also only one outcome modality was assessed. However,
measuring only one modality might lead to a limited view of
differences in pain sensitivity between patients as correla-
tions of the PSQ with other types of experimental pain
testing (cold pressor test, heat, pin prick stimuli, etc.) might
be different. Furthermore, our exclusion criteria included
pain of the arm, neck, or shoulder. Additionally, systemic
diseases, whichmight have their influence on pain sensitivity
(e.g., neurological, cardiac, and/or psychiatric diseases),
were also excluded beforehand. We did not ask for other
pain in the body. As any pain could have impact on pain
sensitivity and thus influence the measurement outcome,
this might have influenced the results.
8 Pain Research and Management
5. Conclusion
Our study shows that the Dutch version of the PSQ was
culturally appropriate for assessing self-reported pain sen-
sitivity in Dutch adults. (e instrument presented high
internal consistency. Construct validity was similar to the
original German version, with weak to moderate correla-
tions between PSQ and experimental pain measures in
healthy adult volunteers.
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